home / stock / coll / coll news


COLL News and Press, Collegium Pharmaceutical Inc.

Stock Information

Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com

Menu

Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...

COLL - As U.S. profit margins near record highs, these small-cap stocks lead on profitability

2026-06-18 07:43:44 ET More on small cap stocks June FOMC Statement: Contrarian Perspective On The Expected Rate Hike Hawkish-Leaning Committee, Reform-Minded Chair: Warsh's First Fed Meeting 'Regime Change; At The Fed: Fed Chair Warsh Makes The First Moves U...

COLL - Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STOUGHTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced it awarded inducement grants on June 1, 2026 under the Company's 2026 Inducement Plan (the 2026 Inducement Plan). The Company granted 50,305 restricted stock units (RSUs), in...

COLL - Collegium to Participate in 2026 Jefferies Global Healthcare Conference

STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference. Details of the event are as follows: Fireside Chat Date and Time:...

COLL - Top 10 small?cap value picks: lowest forward P/Es and strong profitability

2026-05-18 06:43:24 ET More on iShares Core S&P Small-Cap ETF, iShares Russell 2000 ETF, etc. The Major Differences Between This Bull Stock Market And The Late 1990s Weekly Market Pulse: Chokepoints Market Leadership Is Narrow, Increasing Summer Risk From...

COLL - Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Extends Collegium’s Long-Term Revenue Outlook; AZSTARYS has Expected Patent Protection Through 2037 – – Col...

COLL - Collegium (COLL) Q1 2026 Earnings Transcript

2026-05-07 14:36:21 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

COLL - Collegium outlines $805M-$825M 2026 product revenue outlook while planning to close $650M AZSTARYS deal in Q2

2026-05-07 13:52:13 ET More on Collegium Pharmaceutical Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call Transcript Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow Collegium...

COLL - Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call Transcript

2026-05-07 13:51:19 ET Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDT... Read the full article on Seeking Alpha For further details see: Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call Transcript

COLL - Best Small Cap Value Stocks May 2026

2026-05-07 11:08:44 ET Don't forget about us! Many advisors and asset allocation models put a small cap slice into investor's portfolios ( VTWO ) by training and habit. The truth is, small caps have not provided a non-correlated hedging strategy to large cap indexes ( VOO )( I...

COLL - Collegium Pharmaceutical Non-GAAP EPS of $1.76 beats by $0.24, revenue of $193.5M beats by $9.04M

2026-05-07 07:45:32 ET More on Collegium Pharmaceutical Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow Collegium Pharmaceutical: Another M&A Episode Adds To An Intriguing Case Col...

Next 10